Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

The KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease notes that direct-acting antivirals effectively treat ...

Chronic hepatitis C is a growing health problem worldwide that has attracted increased attention in recent years. Treatment with peginterferon and ribavirin combination had previously been the ...

Chronic infection with hepatitis C virus (HCV) is common, but underdiagnosed and undertreated worldwide. The most important treatment outcome in HCV is sustained virological response (SVR), due to its ...

HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens ...

Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...

Compared with no HCV infection, chronic HCV was associated with an increased risk of PDAC after adjusting for risk factors including smoking, alcohol use, diabetes, pancreatitis, and liver disease ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

Chronic hepatitis C infection has been linked to a higher risk of pancreatic cancer. Learn more about findings from a major ...

The study provides strong evidence that chronic HCV infection increases the likelihood of developing PDAC, with certain ...